Yang Yafan, Xue Liyan, Chen Xiankai, Kang Mingqiang, Zhang Renquan, Tian Hui, Ma Jianqun, Fu Maoyong, Wei Jinchang, Liu Qi, Hao Anlin, He Yi, Zhang Ruixiang, Xie Hounai, Xu Lei, Luo Peng, Qin Jianjun, Li Yin
Department of Anaesthesiology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Pathology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Thorac Cancer. 2025 Jan;16(1):e15504. doi: 10.1111/1759-7714.15504.
This study aimed to analyze lymph node metastasis (LNM) distribution in superficial esophageal squamous cell carcinoma (ESCC) and its impact factors on survival.
We reviewed 241 pT1N+ ESCC cases between February 2012 and April 2022 from 10 Chinese hospitals with a high volume of esophageal cancer (EC). We analyzed clinicopathological data to identify overall survival (OS) risk factors and LNM distribution in relation to tumor invasion depth.
Of the 241 patients, 26 (10.8%) had pT1a cancer and 215 (89.2%) had pT1b cancer. We showed that N3 stage, ≤ 28 lymphadenectomies, and nerve infiltration (NI) were negative factors for OS in superficial pN+ ESCC, whereas the OS was not definitively affected by the tumor depth and the choice of adjuvant therapy. In general, the LNM rates of the 193 pT1N+ ESCC cases can be ranked in the following order: station 106recR > station 106recL > station 1 > station 7 > station 2. With deeper tumor invasion, the higher LNM rate was observed near the bilateral recurrent laryngeal nerves (RLN), but there was no statistically significant difference.
In superficial ESCC, LNM was frequently observed along the 106recR (35.8%) and 106recL (25.6%) stations. Advanced N-staging (N3) was a major negative impact factor in prognosis, and adequate lymph nodes dissected (LND) (N > 28) improved OS of pT1N+ ESCC. However, in superficial ESCC, tumor infiltration depth did not affect patients' OS or the distribution of positive LNs. The optimal adjuvant treatment that favors survival for these patients required further investigation.
本研究旨在分析食管鳞状细胞癌(ESCC)浅表型的淋巴结转移(LNM)分布情况及其对生存的影响因素。
我们回顾了2012年2月至2022年4月期间来自10家食管癌(EC)病例量大的中国医院的241例pT1N+ ESCC病例。我们分析临床病理数据以确定总生存(OS)危险因素以及与肿瘤浸润深度相关的LNM分布情况。
在这241例患者中,26例(10.8%)为pT1a期癌,215例(89.2%)为pT1b期癌。我们发现,N3期、≤28枚淋巴结清扫以及神经浸润(NI)是浅表pN+ ESCC患者OS的负面因素,而肿瘤深度和辅助治疗的选择对OS没有明确影响。总体而言,193例pT1N+ ESCC病例的LNM率可按以下顺序排列:106recR站>106recL站>1站>7站>2站。随着肿瘤浸润加深,双侧喉返神经(RLN)附近的LNM率更高,但无统计学显著差异。
在ESCC浅表型中,LNM常见于106recR站(35.8%)和106recL站(25.6%)。N分期进展(N3)是预后的主要负面影响因素,充分的淋巴结清扫(LND)(N>28)可改善pT1N+ ESCC患者的OS。然而,在ESCC浅表型中,肿瘤浸润深度不影响患者的OS或阳性淋巴结的分布。有利于这些患者生存的最佳辅助治疗需要进一步研究。